[Hirudin is superior to heparin in reducing cardiovascular mortality, infarct and refractory angina in patients with unstable angina or myocardial infarct without elevation of the ST tract].
Franzosi
M G
MG
Dipartimento di Ricerca Cardiovascolare Istituto di Ricerche Farmacologiche Mario Negri Milano.
D000789:Angina, Unstable / Q000188:drug therapy* / Q000401:mortality; D000925:Anticoagulants / Q000627:therapeutic use*; D002318:Cardiovascular Diseases / Q000401:mortality; D004562:Electrocardiography; D006493:Heparin / Q000627:therapeutic use*; D024764:Hirudin Therapy; D006801:Humans; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality; D016032:Randomized Controlled Trials as Topic
D000925:Anticoagulants; D006493:Heparin